Engineering the perfect (bacterial) cancer therapy

被引:624
作者
Forbes, Neil S. [1 ]
机构
[1] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA
基金
美国国家卫生研究院;
关键词
ATTENUATED SALMONELLA-TYPHIMURIUM; ENTERICA-SEROVAR-TYPHIMURIUM; MURINE TUMOR-MODELS; ENZYME-PRODRUG THERAPY; ESCHERICHIA-COLI NISSLE-1917; POSITRON-EMISSION-TOMOGRAPHY; PROTEIN EXPRESSION THERAPY; GENE-THERAPY; IN-VIVO; TARGETING SALMONELLA;
D O I
10.1038/nrc2934
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
引用
收藏
页码:784 / 793
页数:10
相关论文
共 139 条
[71]   Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo [J].
Loessner, Holger ;
Endmann, Anne ;
Leschner, Sara ;
Westphal, Kathrin ;
Rohde, Manfred ;
Miloud, Tewfik ;
Haemmerling, Guenter ;
Neuhaus, Klaus ;
Weiss, Siegfried .
CELLULAR MICROBIOLOGY, 2007, 9 (06) :1529-1537
[72]   Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo [J].
Low, KB ;
Ittensohn, M ;
Le, T ;
Platt, J ;
Sodi, S ;
Amoss, M ;
Ash, O ;
Carmichael, E ;
Chakraborty, A ;
Fischer, J ;
Lin, SL ;
Luo, X ;
Miller, SI ;
Zheng, LM ;
King, I ;
Pawelek, JM ;
Bermudes, D .
NATURE BIOTECHNOLOGY, 1999, 17 (01) :37-41
[73]   Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models [J].
Luo, X ;
Li, ZJ ;
Lin, S ;
Le, T ;
Ittensohn, M ;
Bermudes, D ;
Runyab, JD ;
Shen, SY ;
Chen, JP ;
King, IC ;
Zheng, LM .
ONCOLOGY RESEARCH, 2001, 12 (11-12) :501-508
[74]   Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model [J].
Maletzki, C. ;
Linnebacher, M. ;
Kreikemeyer, B. ;
Emmrich, J. .
GUT, 2008, 57 (04) :483-491
[75]  
MALMGREN RA, 1955, CANCER RES, V15, P473
[76]  
Mei SP, 2002, ANTICANCER RES, V22, P3261
[77]   Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella [J].
Mengesha, Asferd ;
Dubois, Ludwig ;
Lambin, Philippe ;
Landuyt, Willy ;
Chiu, Roland K. ;
Wouters, Bradly G. ;
Theys, Jan .
CANCER BIOLOGY & THERAPY, 2006, 5 (09) :1120-1128
[78]   Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals [J].
Min, Jung-Joon ;
Nguyen, Vu H. ;
Kim, Hyun-Ju ;
Hong, Yeongjin ;
Choy, Hyon E. .
NATURE PROTOCOLS, 2008, 3 (04) :629-636
[79]   Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli [J].
Min, Jung-Joon ;
Kim, Hyun-Ju ;
Park, Jae Hyo ;
Moon, Sungmin ;
Jeong, Jae Ho ;
Hong, Yeoung-Jin ;
Cho, Kyoung-Oh ;
Nam, Jong Hee ;
Kim, Nacksung ;
Park, Young-Kyu ;
Bom, Hee-Seung ;
Rhee, Joon Haeng ;
Choy, Hyon E. .
MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (01) :54-61
[80]   Drug penetration in solid tumours [J].
Minchinton, Andrew I. ;
Tannock, Ian F. .
NATURE REVIEWS CANCER, 2006, 6 (08) :583-592